StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.07−0.09 (-1.10%)

Close on Nov 18, 2026Market cap $465.53MP/E –Yield –

Kamada net income

Net income is the profit left for shareholders after every expense, interest and tax.

Kamada's net income for the twelve months ending Sep 30, 2025 was $20.44M, up 30.1% year over year. For fiscal 2024 it was $14.46M, up 74.6% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2024Dec 31, 2024$14.46M+74.6%
FY2023Dec 31, 2023$8.28M–
FY2022Dec 31, 2022-$2.32M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$5.30M+37.1%
Q2 FY2025Jun 30, 2025$7.38M+66.7%
Q1 FY2025Mar 31, 2025$3.96M+67.6%
Q4 FY2024Dec 31, 2024$3.81M-24.7%
Q3 FY2024Sep 30, 2024$3.86M+19.9%
Q2 FY2024Jun 30, 2024$4.43M+144.3%
Q1 FY2024Mar 31, 2024$2.37M–
Q4 FY2023Dec 31, 2023$5.06M–
Q3 FY2023Sep 30, 2023$3.22M+665809.1%
Q2 FY2023Jun 30, 2023$1.81M–
Q1 FY2023Mar 31, 2023-$1.81K–
Q4 FY2022Dec 31, 2022-$2.32M–
Q3 FY2022Sep 30, 2022$484–
Q2 FY2022Jun 30, 2022-$3.92M–

More Kamada figures

See a number that looks wrong?